Catalent Pharma Solutions To Present At The Morgan Stanley 2014 Global Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that John Chiminski, President & Chief Executive Officer, and Matthew Walsh, Executive Vice President & Chief Financial Officer, will present at the Morgan Stanley 2014 Global Healthcare Conference at 12:55 p.m. ET on Wednesday, September 10, 2014.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC